Axsome Therapeutics (AXSM) PT Raised to $220 at Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. SPY
8. UNH
9. SBUX
10. AXP

Go back to Axsome Therapeutics (AXSM) PT Raised to $220 at Oppenheimer

Axsome Therapeutics (AXSM) PT Raised to $230 at B.Riley

January 2, 2026 9:37 AM EST

B.Riley analyst Madison El-Saadi raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $230.00 (from $184.00) while maintaining a Buy rating.

... More

Baird on Axsome Therapeutics (AXSM): 'Incrementally positive on regulatory updates'

December 31, 2025 1:54 PM EST

Baird analyst Joel Beatty reiterated an Outperform rating and $157.00 price target on Axsome Therapeutics (NASDAQ: AXSM).

The analyst comments "Incrementally positive on regulatory updates. Axsome announced two New Year's Eve regulatory updates, with their sNDA for AXS-05 (Auvelity) in Alzheimer's agitation... More

Leerink on Axsome Therapeutics (AXSM): 'This is very positive news'

December 31, 2025 1:20 PM EST

Leerink Partners analyst Marc Goodman reiterated an Outperform rating and $150.00 price target on Axsome Therapeutics (NASDAQ: AXSM).

The analyst comments "This is very positive news for Axsome, as Alzheimer's disease agitation (AD-A) is a key additional indication to drive... More